Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Comput Math Methods Med ; 2014: 427826, 2014.
Article in English | MEDLINE | ID: mdl-25478003

ABSTRACT

Patients with Parkinson's disease (PD) can exhibit a reduction of spontaneous facial expression, designated as "facial masking," a symptom in which facial muscles become rigid. To improve clinical assessment of facial expressivity of PD, this work attempts to quantify the dynamic facial expressivity (facial activity) of PD by automatically recognizing facial action units (AUs) and estimating their intensity. Spontaneous facial expressivity was assessed by comparing 7 PD patients with 8 control participants. To voluntarily produce spontaneous facial expressions that resemble those typically triggered by emotions, six emotions (amusement, sadness, anger, disgust, surprise, and fear) were elicited using movie clips. During the movie clips, physiological signals (facial electromyography (EMG) and electrocardiogram (ECG)) and frontal face video of the participants were recorded. The participants were asked to report on their emotional states throughout the experiment. We first examined the effectiveness of the emotion manipulation by evaluating the participant's self-reports. Disgust-induced emotions were significantly higher than the other emotions. Thus we focused on the analysis of the recorded data during watching disgust movie clips. The proposed facial expressivity assessment approach captured differences in facial expressivity between PD patients and controls. Also differences between PD patients with different progression of Parkinson's disease have been observed.


Subject(s)
Face/physiology , Facial Expression , Parkinson Disease/physiopathology , Pattern Recognition, Automated , Adult , Aged , Algorithms , Case-Control Studies , Databases, Factual , Electrocardiography/methods , Electromyography/methods , Emotions , Facial Muscles/pathology , Female , Humans , Image Processing, Computer-Assisted/methods , Male , Middle Aged , Muscle Rigidity , Parkinson Disease/diagnosis , Pilot Projects , Recognition, Psychology , Young Adult
2.
Eur J Med Chem ; 43(4): 741-8, 2008 Apr.
Article in English | MEDLINE | ID: mdl-17658668

ABSTRACT

The synthesis of a ligand containing a nitrobenzyl group as bioreductive pharmacophore and the preparation of the corresponding technetium and rhenium complexes are presented. (99m)Tc labelling was performed in high yield (>90%) by ligand substitution using fac-[(99m)Tc(CO)(3)(H(2)O)(3)](+) as precursor. The structure of the technetium complex was established by chromatographic comparison with the analogous rhenium compound which was fully characterized by elemental analysis, spectroscopic methods and X-ray crystallography. Reduction potential of the rhenium complex was in the characteristic range for bioreductive compounds. Biodistribution in normal mice was characterized by fast blood and soft tissue depuration and combined excretion via the hepatobiliary and urinary systems. Tumour uptake was low, probably due to low lipophilicity but tumour/muscle ratios were favourable as a consequence of high excretion.


Subject(s)
Organotechnetium Compounds/chemical synthesis , Radiopharmaceuticals/chemical synthesis , Rhenium/chemistry , Animals , Cell Hypoxia , Crystallography, X-Ray , Diagnostic Imaging , In Vitro Techniques , Liver/metabolism , Lung/metabolism , Mice , Models, Molecular , Molecular Structure , Organotechnetium Compounds/pharmacokinetics , Radiopharmaceuticals/pharmacokinetics , Sarcoma, Experimental/drug therapy , Sarcoma, Experimental/etiology , Sarcoma, Experimental/metabolism , Spectrophotometry, Infrared , Structure-Activity Relationship , Tissue Distribution , Xenograft Model Antitumor Assays
3.
Inorg Chem ; 45(2): 902-9, 2006 Jan 23.
Article in English | MEDLINE | ID: mdl-16411729

ABSTRACT

The reaction of 2-(2'-pyridyl)benzothiazole, [NN], with the ReO(V)(3+) and TcO(V)(3+) cores in the presence of thiophenols, [S] (RC(6)H(4)SH, R = H, 4-CH(3), 4-OCH(3)), as coligands led to the isolation of hexacoordinated complexes of the MO[NN][S](3) type (M = Re, Tc). In all cases, two geometric mer isomers were formed, as evidenced by NMR spectroscopy and confirmed by X-ray crystallography. In both isomers, the coordination geometry about the metal ion is a distorted octahedral defined by the two nitrogen atoms of the bidentate ligand, the three sulfur atoms of the monodentate thiols, and the oxygen atom of the oxo group. The apical positions of the octahedron are occupied by the oxygen of the oxo group and, in one of the isomers, the nitrogen of the pyridyl moiety of 2-(2'-pyridyl)benzothiazole, while, in the second isomer, the imine nitrogen of 2-(2'-pyridyl)benzothiazole. The complexes are stable, neutral, and lipophilic. Complete (1)H and (13)C NMR assignments are reported for all complexes. The synthetic reaction was also successfully transferred at the technetium-99m tracer level by ligand exchange reaction using (99m)Tc-glucoheptonate as precursor in the presence of 2-(2'-pyridyl)benzothiazole and 4-CH(3)C(6)H(4)SH. The structure of the technetium-99m complex was established by high-performance liquid chromatographic comparison with the analogous oxotechnetium and oxorhenium complexes. The 2-(2'-pyridyl)benzothiazole ligand serves as a preliminary model for 2-(4-aminophenyl)benzothiazole, which possesses interesting properties for the development of technetium and rhenium radiopharmaceuticals for tumor imaging and/or radiotherapy as well as in vivo diagnosis of Alzheimer's disease.


Subject(s)
Organometallic Compounds/chemistry , Organotechnetium Compounds/chemistry , Radiopharmaceuticals/chemistry , Rhenium/chemistry , Technetium/chemistry , Thiazoles/chemistry , Alzheimer Disease/diagnosis , Cell Line, Tumor , Crystallography, X-Ray , Humans , Ligands , Magnetic Resonance Spectroscopy , Models, Molecular , Molecular Structure , Organometallic Compounds/chemical synthesis , Organometallic Compounds/pharmacokinetics , Organotechnetium Compounds/chemical synthesis , Oxidation-Reduction , Phenols/chemistry , Radiopharmaceuticals/chemical synthesis , Radiopharmaceuticals/pharmacokinetics , Sensitivity and Specificity , Stereoisomerism , Sulfhydryl Compounds/chemistry
SELECTION OF CITATIONS
SEARCH DETAIL
...